Median Technologies Announces Outstanding Lung Nodule Detection (CADe1) Performance for iBiopsy Lung Cancer Screening
iBiopsy Lung Cancer Screening (LCS) detection performance reaches 94.9% sensitivity for a false positive rate of 1 per CT scan, a performance superior to that of lung CADe systems currently on the